-$0.13 EPS Expected for Orthopediatrics Corp (KIDS) This Quarter

Analysts expect Orthopediatrics Corp (NASDAQ:KIDS) to announce earnings per share (EPS) of ($0.13) for the current quarter, Zacks reports. Two analysts have issued estimates for Orthopediatrics’ earnings. The firm is scheduled to announce its next quarterly earnings report on Wednesday, February 14th.

On average, analysts expect that Orthopediatrics will report full-year earnings of ($1.41) per share for the current financial year. For the next fiscal year, analysts anticipate that the business will post earnings of ($0.27) per share, with EPS estimates ranging from ($0.29) to ($0.25). Zacks’ earnings per share averages are a mean average based on a survey of sell-side research firms that that provide coverage for Orthopediatrics.

KIDS has been the topic of a number of recent analyst reports. Stifel Nicolaus initiated coverage on shares of Orthopediatrics in a report on Monday, November 6th. They issued a “buy” rating and a $23.00 price target on the stock. BTIG Research reissued a “buy” rating and issued a $24.00 price target on shares of Orthopediatrics in a report on Friday, January 5th. William Blair initiated coverage on shares of Orthopediatrics in a report on Monday, November 6th. They issued an “outperform” rating on the stock. BidaskClub downgraded shares of Orthopediatrics from a “hold” rating to a “sell” rating in a report on Tuesday, January 9th. Finally, Piper Jaffray Companies started coverage on shares of Orthopediatrics in a report on Monday, November 6th. They issued an “overweight” rating and a $24.00 price target on the stock. Two research analysts have rated the stock with a sell rating and four have assigned a buy rating to the company. The stock presently has an average rating of “Hold” and a consensus price target of $23.67.

Shares of Orthopediatrics (NASDAQ KIDS) opened at $17.30 on Monday. Orthopediatrics has a fifty-two week low of $15.85 and a fifty-two week high of $23.00. The company has a debt-to-equity ratio of -0.38, a quick ratio of 1.00 and a current ratio of 2.78.

Several hedge funds have recently bought and sold shares of the stock. DF Dent & Co. Inc. bought a new position in shares of Orthopediatrics in the fourth quarter worth approximately $1,794,000. TIAA CREF Investment Management LLC bought a new position in shares of Orthopediatrics in the fourth quarter worth approximately $130,000. Teachers Advisors LLC bought a new position in shares of Orthopediatrics in the fourth quarter worth approximately $102,000. California State Teachers Retirement System bought a new position in shares of Orthopediatrics in the fourth quarter worth approximately $141,000. Finally, Deutsche Bank AG bought a new position in shares of Orthopediatrics in the fourth quarter worth approximately $196,000. Institutional investors own 1.58% of the company’s stock.

COPYRIGHT VIOLATION NOTICE: “-$0.13 EPS Expected for Orthopediatrics Corp (KIDS) This Quarter” was first published by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are reading this article on another domain, it was illegally copied and reposted in violation of U.S. & international trademark & copyright legislation. The correct version of this article can be accessed at https://www.dispatchtribunal.com/2018/02/19/0-13-eps-expected-for-orthopediatrics-corp-kids-this-quarter.html.

About Orthopediatrics

OrthoPediatrics Corp. is a medical device company. The Company designs, develops and commercializes orthopedic implants and instruments to meet the specialized needs of pediatric surgeons and their patients. It operates through the OrthoPediatrics segment, which designs, develops and markets implants and devices for children with orthopedic problems.

Get a free copy of the Zacks research report on Orthopediatrics (KIDS)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Orthopediatrics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Orthopediatrics and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply